New insider activity at Idexx Laboratories ( (IDXX) ) has taken place on March 5, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EVP Nimrata Hunt of Idexx Laboratories has recently sold 1,758 shares of the company’s stock in a transaction valued at $1,115,574, signaling a notable executive-level move within the firm’s insider activity.
Spark’s Take on IDXX Stock
According to Spark, TipRanks’ AI Analyst, IDXX is a Outperform.
The score is anchored by strong financial quality (premium margins, solid free cash flow, and improved balance sheet) and supportive 2026 guidance. Offsetting factors are weak current technical momentum and a high P/E that leaves less room for error, with corporate execution risk around the CEO transition as a secondary consideration.
To see Spark’s full report on IDXX stock, click here.
More about Idexx Laboratories
YTD Price Performance: -4.11%
Average Trading Volume: 511,279
Technical Sentiment Signal: Buy
Current Market Cap: $50.6B